MedPath

AYURVEDIC MANAGEMENT FOR ENDOMETRIOSIS

Phase 3
Conditions
Health Condition 1: N801- Endometriosis of ovary
Registration Number
CTRI/2022/05/042739
Lead Sponsor
Institute of Teaching and Research in Ayurveda Jamnagar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.patients either asymptomatic or having clinical signs and symptoms of endometriosis

2.patients eligible for Virechana karma and Basti karma

3.patients having CA-125 level <500 U/mL

4.women with Hb >7 gm%

Exclusion Criteria

1.patient having chocolate cyst size greater than or equal to 7 cm as per USG report

2.pregnant women with endometriosis

3.women with Hb <7 gm%

4.suspected carcinoma of reproductive tract

5.patient with infectious diseases of reproductive tract like tuberculosis, sexually transmitted diseases

6.congenital anomaly of reproductive tract

7.patients with history of cardiac diseases, chronic liver disease, uncontrolled hypertension (systolic BP above 160 & Diastolic above 100 mmHg), uncontrolled diabetes mellitus (above the range of 160 mg/dl-RBS)

8.patients not eligible for Virechana karma and Basti

9.patients having CA_125 level >500 U/M

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in the size of endometriosis by using USG findings according to American Society for Reproductive Medicine Revised Classification of Endometriosis & Changes in Value of CA-125 and reduction in Dysmenorrhoea, Dyspareunia and deep seated pelvic pain by using VAS score and Scale.Timepoint: B.T.(0 day) and A.T.(After 3 months)
Secondary Outcome Measures
NameTimeMethod
Improvement in cardinal and associated clinical features related to endometriosis i.e.menorrhagia, premenstrual bleeding and intermenstrual bleeding,vomiting,dyschezia, dysuria.Timepoint: B.T.(0 day) and A.T.(after 3 months)
© Copyright 2025. All Rights Reserved by MedPath